» Articles » PMID: 37920115

Common Mental Health Disorders and Cognitive Decline in a Longitudinal Down Syndrome Cohort

Overview
Journal BJPsych Open
Specialty Psychiatry
Date 2023 Nov 3
PMID 37920115
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Down syndrome is the most common genetic cause of intellectual disability and Alzheimer's disease. In the general population, common mental disorders (CMDs), including anxiety, depression and obsessive-compulsive disorder, are linked to cognitive decline and higher risk for dementia. It is not known how CMDs affect longer-term cognitive outcomes in Down syndrome, and there is often diagnostic uncertainty in older people with Down syndrome and psychiatric comorbidity.

Aims: To study the influence of CMDs on cognitive ability and whether they are related longitudinally to development of clinical signs of Alzheimer's disease in Down syndrome.

Method: We followed 115 individuals with Down syndrome, 27 of whom were diagnosed with a CMD, over approximately 3 years. Changes in cognitive and behavioural outcomes between baseline and follow-up assessment were analysed, with comparisons made between those with and without a comorbid CMD. Age, gender, apolipoprotein E status and level of intellectual disability were included as covariates.

Results: No significant association between presence of a CMD and poorer performance on cognitive tasks or informant-rated decline over time was observed ( > 0.05).

Conclusions: Our results suggest that a diagnosis of a CMD does not have a significant negative effect on long-term cognitive or behavioural outcomes in individuals with Down syndrome. In individuals with stable or treated CMD, subsequent cognitive decline is likely indicative of Alzheimer's disease rather than a consequence of mental disorder.

Citing Articles

Editorial on common mental health disorders and cognitive decline in a longitudinal Down syndrome cohort.

Tromans S, Desarkar P BJPsych Open. 2024; 10(3):e77.

PMID: 38602197 PMC: 11060088. DOI: 10.1192/bjo.2024.16.

References
1.
Strydom A, Livingston G, King M, Hassiotis A . Prevalence of dementia in intellectual disability using different diagnostic criteria. Br J Psychiatry. 2007; 191:150-7. DOI: 10.1192/bjp.bp.106.028845. View

2.
Startin C, DSouza H, Ball G, Hamburg S, Hithersay R, Hughes K . Health comorbidities and cognitive abilities across the lifespan in Down syndrome. J Neurodev Disord. 2020; 12(1):4. PMC: 6979347. DOI: 10.1186/s11689-019-9306-9. View

3.
McIntyre R, Lophaven S, Olsen C . A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol. 2014; 17(10):1557-67. PMC: 4162519. DOI: 10.1017/S1461145714000546. View

4.
Urv T, Zigman W, Silverman W . Psychiatric symptoms in adults with Down syndrome and Alzheimer's disease. Am J Intellect Dev Disabil. 2010; 115(4):265-76. DOI: 10.1352/1944-7558-115.4.265. View

5.
Collacott R, Cooper S . Adaptive behavior after depressive illness in Down's syndrome. J Nerv Ment Dis. 1992; 180(7):468-70. DOI: 10.1097/00005053-199207000-00012. View